By
Latest Stories
Don’t miss our hot and upcoming stories
Merck (HQ Germany) Strengthens AI-Driven Drug Discovery with Strategic Partnerships with BenevolentAI and Exscientia
Darmstadt, Germany – Sept 20, 2023 Advancing AI-Powered Drug Development in Oncology, Neurology, and Immunology…
BenevolentAI Announces Strategic Collaboration with Merck, Darmstadt, Germany
London, UK – Sept 20, 2023 Partnership Utilizes AI-Driven Drug Discovery to Advance Oncology, Neurology,…
XtalPi and Eli Lilly Partner in $250M AI-Driven Drug Discovery Collaboration
Cambridge, MA – June 1 2023 XtalPi Inc., a pioneering AI-powered pharmaceutical technology company, has…
XtalPi and Janssen Partner to Accelerate AI-Driven Small Molecule Drug Discovery
Shenzhen, China – Oct 27 2022 XtalPi Inc., a leading AI-powered pharmaceutical technology company, announced…